Dermatology News

Four injectable hyaluronic acid gels used as dermal filler have received the EU Medical Device Regulation certification, making the products commercially available in the European Union, Evolus Inc. announced in a press release.

A study on cancer-causing benzene in acne products was Healio Dermatology’s most-read article of October, with coverage from clinical meetings also garnering attention.

Patients with primary thyroid cancer who received radioactive iodine exhibited increased risk for melanoma and other nonkeratinocyte skin cancers, according to study results.

The FDA has issued a 510(k) clearance to Imbed Biosciences to market Microlyte Ag/Lidocaine for the management of painful skin wounds, the company announced in a press release.

ORLANDO — A synchronous ultrasound parallel beam device delivered positive outcomes in perioral rejuvenation, according to a presentation at the American Society for Dermatologic Surgery Annual Meeting.

As a physician, your career will be rewarding in many ways, including a personal sense of purpose, ability to help others and the potential for high-earning power.

The FDA granted rare pediatric disease designation for BPM31510T for the treatment of epidermolysis bullosa, BPGbio announced in a press release.

ORLANDO — Certain Mohs surgery repair types raised the risk for healing complications following adjuvant radiation therapy, according to a presentation at the American Society for Dermatologic Surgery Annual Meeting.

Lack of health insurance contributes to a high percentage of racial and ethnic disparities in advanced-stage diagnoses for several cancer types, according to results of a mediation analysis.

New data showed Winlevi reduced oil production, remained stable when used in conjunction with other topical acne medications and improved outcomes in skin of color, Sun Pharma announced in a press release.